Histologic and Molecular Subtype of CHEK2 and PALB2 Associated Breast Cancers

被引：0
|
作者：
Agarwal, Indu [1 ]
Sullivan, Megan E. [1 ]
机构：
[1] NorthShore Univ Hlth Syst, Evanston, IL USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
124
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] Title: Histologic and Molecular Subtype of CHEK2 and PALB2 Associated Breast Cancers
    Agarwal, Indu
    Sullivan, Megan E.
    MODERN PATHOLOGY, 2018, 31 : 43 - 43
  • [2] Managing Patient with Mutations in PALB2, CHEK2, or ATM
    Acevedo F.
    Deng Z.
    Armengol V.D.
    Hughes K.
    Current Breast Cancer Reports, 2018, 10 (2) : 74 - 82
  • [3] Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations
    Bergstrom, Colin
    Pence, Colton
    Berg, Jordan
    Partain, Natalia
    Sadeghi, Navid
    Mauer, Caitlin
    Pirzadeh-Miller, Sara
    Gao, Ang
    Li, Hsiao
    Unni, Nisha
    Syed, Samira
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3383 - 3393
  • [4] Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations
    Colin Bergstrom
    Colton Pence
    Jordan Berg
    Natalia Partain
    Navid Sadeghi
    Caitlin Mauer
    Sara Pirzadeh-Miller
    Ang Gao
    Hsiao Li
    Nisha Unni
    Samira Syed
    Annals of Surgical Oncology, 2021, 28 : 3383 - 3393
  • [5] Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations
    Infante, Mar
    Arranz-Ledo, Monica
    Lastra, Enrique
    Olaverri, Amaya
    Ferreira, Raquel
    Orozco, Marta
    Hernandez, Lara
    Martinez, Noemi
    Duran, Mercedes
    CLINICA CHIMICA ACTA, 2024, 552
  • [6] Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model
    Lee, Andrew J.
    Cunningham, Alex P.
    Tischkowitz, Marc
    Simard, Jacques
    Pharoah, Paul D.
    Easton, Douglas F.
    Antoniou, Antonis C.
    GENETICS IN MEDICINE, 2016, 18 (12) : 1190 - 1198
  • [7] Diagnosis, management, and surveillance for patients with PALB2, CHEK2, and ATM gene mutations
    Krupa, Kelly
    Kowzun, Maria
    Potdevin, Lindsay
    Kumar, Shicha
    Eladoumikdachi, Firas
    Fencer, Maria
    Bleich, Gabrielle
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 143 - 143
  • [8] Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort
    McInerney, N. M.
    Miller, N.
    Rowan, A.
    Colleran, G.
    Barclay, E.
    Curran, C.
    Kerin, M. J.
    Tomlinson, I. P.
    Sawyer, E.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (01) : 203 - 210
  • [9] Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer
    Woodward, Emma R.
    van Veen, Elke M.
    Forde, Claire
    Harkness, Elaine F.
    Byers, Helen J.
    Ellingford, Jamie M.
    Burghel, George J.
    Schlech, Helene
    Bowers, Naomi L.
    Wallace, Andrew J.
    Howell, Sacha J.
    Howell, Anthony
    Lalloo, Fiona
    Newman, William G.
    Smith, Miriam J.
    Gareth Evans, D.
    GENETICS IN MEDICINE, 2021, 23 (10) : 1969 - 1976
  • [10] Evaluation of variants in BRIP1, PALB2 and CHEK2 in a west of Ireland breast cancer cohort
    Mc Inerney, N. M.
    Miller, N.
    Rowan, A.
    Colleran, G.
    Curran, C.
    Ian, T.
    Eli, S.
    Michael, K. J.
    CANCER RESEARCH, 2009, 69 (02) : 229S - 230S
12345